The role of apoptosis versus oncotic necrosis in liver injury: Facts or faith?

Journal of Hepatology

Volumn 44, Issue 5, 2006, Pages 984-993

  Schulze Bergkamen, Henning ^a   Schuchmann, Marcus ^a   Fleischer, Binje ^a   Galle, Peter R ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CATHEPSIN; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1BETA; PROTEIN BCL 2; TUMOR NECROSIS FACTOR;

ANOIKIS; APOPTOSIS; AUTOPHAGY; CELL AGING; CELL DEATH; CELL SURVIVAL; CHOLESTASIS; EPITHELIUM CELL; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER TOXICITY; NECROSIS; PARAPTOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; LIVER; LIVER DISEASES; NECROSIS;

EID: 33645770746     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.02.004     Document Type: Review

References (107)

1. Krammer P.H. CD95's deadly mission in the immune system. Nature 407 (2000) 789-795
2. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
3. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
4. Canbay A., Friedman S., and Gores G.J. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39 (2004) 273-278
5. Mori E., Thomas M., Motoki K., Nakazawa K., Tahara T., Tomizuka K., et al. Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2. Cell Death Differ 11 (2004) 203-207
6. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Eur. Mol. Biol. Org. J 14 (1995) 5579-5588
7. Walczak H., and Sprick M.R. Biochemistry and function of the DISC. Trends Biochem Sci 26 (2001) 452-453
8. Lavrik I., Golks A., and Krammer P.H. Death receptor signaling. J Cell Sci 118 (2005) 265-267
9. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. Eur. Mol. Biol. Org. J 17 (1998) 1675-1687
10. Li S., Zhao Y., He X., Kim T.H., Kuharsky D.K., Rabinowich H., et al. Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem 277 (2002) 26912-26920
11. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
12. Jones R.A., Johnson V.L., Buck N.R., Dobrota M., Hinton R.H., Chow S.C., et al. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology 27 (1998) 1632-1642
13. Kronenberger B., Wagner M., Herrmann E., Mihm U., Piiper A., Sarrazin C., et al. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J Viral Hepat 12 (2005) 307-314
14. Bantel H., Lugering A., Poremba C., Lugering N., Held J., Domschke W., et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 34 (2001) 758-767
15. Seidel N., Volkmann X., Langer F., Flemming P., Manns M.P., Schulze-Osthoff K., et al. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology 42 (2005) 113-120
16. Jaattela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23 (2004) 2746-2756
17. Schotte P., Van Criekinge W., Van de Craen M., Van Loo G., Desmedt M., Grooten J., et al. Cathepsin B-mediated activation of the proinflammatory caspase-11. Biochem Biophys Res Commun 251 (1998) 379-387
18. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106 (2000) 1127-1137
19. Werneburg N.W., Guicciardi M.E., Bronk S.F., and Gores G.J. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 283 (2002) G947-G956
20. Roberts L.R., Adjei P.N., and Gores G.J. Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem Biophys 30 (1999) 71-88
21. Guicciardi M.E., Miyoshi H., Bronk S.F., and Gores G.J. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am J Pathol 159 (2001) 2045-2054
22. Baskin-Bey E.S., Canbay A., Bronk S.F., Werneburg N., Guicciardi M.E., Nyberg S.L., et al. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am J Physiol Gastrointest Liver Physiol 288 (2005) G396-G402
23. Canbay A., Guicciardi M.E., Higuchi H., Feldstein A., Bronk S.F., Rydzewski R., et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 112 (2003) 152-159
24. Gujral J.S., Liu J., Farhood A., and Jaeschke H. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 40 (2004) 998-1007
25. Jaeschke H., and Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125 (2003) 1246-1257
26. Miyoshi H., Rust C., Roberts P.J., Burgart L.J., and Gores G.J. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117 (1999) 669-677
27. Patel T., Roberts L.R., Jones B.A., and Gores G.J. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis 18 (1998) 105-114
28. Ribeiro P.S., Cortez-Pinto H., Sola S., Castro R.E., Ramalho R.M., Baptista A., et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 99 (2004) 1708-1717
29. Feldstein A.E., Canbay A., Angulo P., Taniai M., Burgart L.J., Lindor K.D., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437-443
30. Guicciardi M.E., and Gores G.J. Apoptosis: a mechanism of acute and chronic liver injury. Gut 54 (2005) 1024-1033
31. Galle P.R., Hofmann W.J., Walczak H., Schaller H., Otto G., Stremmel W., et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182 (1995) 1223-1230
32. Galle P.R., and Krammer P.H. CD95-induced apoptosis in human liver disease. Semin Liver Dis 18 (1998) 141-151
33. Faubion W.A., and Gores G.J. Death receptors in liver biology and pathobiology. Hepatology 29 (1999) 1-4
34. Strand S., Hofmann W.J., Grambihler A., Hug H., Volkmann M., Otto G., et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 4 (1998) 588-593
35. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., et al. Lethal effect of the anti-Fas antibody in mice. Nature 364 (1993) 806-809
36. Schulze-Bergkamen H., Untergasser A., Dax A., Vogel H., Buchler P., Klar E., et al. Primary human hepatocytes-a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol 38 (2003) 736-744
37. Reinehr R., and Haussinger D. Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95. Gastroenterology 126 (2004) 249-262
38. Strand S., Strand D., Seufert R., Mann A., Lotz J., Blessing M., et al. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology 126 (2004) 849-858
39. Canbay A., Higuchi H., Bronk S.F., Taniai M., Sebo T.J., and Gores G.J. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123 (2002) 1323-1330
40. Ramadori G., and Saile B. Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology 127 (2004) 997-1000
41. Schoemaker M.H., Ros J.E., Homan M., Trautwein C., Liston P., Poelstra K., et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 36 (2002) 742-750
42. Miyoshi H., Rust C., Guicciardi M.E., and Gores G.J. NF-kappaB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 158 (2001) 967-975
43. Schulze-Bergkamen H., Brenner D., Krueger A., Suess D., Fas S.C., Frey C.R., et al. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 39 (2004) 645-654
44. Bradham C.A., Qian T., Streetz K., Trautwein C., Brenner D.A., and Lemasters J.J. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 18 (1998) 6353-6364
45. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
46. Bellas R.E., FitzGerald M.J., Fausto N., and Sonenshein G.E. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. Am J Pathol 151 (1997) 891-896
47. Schuchmann M., and Galle P.R. Dead or alive-NF-kappaB, the guardian which tips the balance. J Hepatol 36 (2002) 827-828
48. Majno G., and Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146 (1995) 3-15
49. Lemasters J.J., DiGuiseppi J., Nieminen A.L., and Herman B. Blebbing, free Ca2+ and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 325 (1987) 78-81
50. Fickert P., Trauner M., Fuchsbichler A., Zollner G., Wagner M., Marschall H.U., et al. Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol 42 (2005) 378-385
51. Schoemaker M.H., Gommans W.M., Conde de la Rosa L., Homan M., Klok P., Trautwein C., et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 39 (2003) 153-161
52. Schwab B.L., Guerini D., Didszun C., Bano D., Ferrando-May E., Fava E., et al. Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ 9 (2002) 818-831
53. Jaeschke H., Gores G.J., Cederbaum A.I., Hinson J.A., Pessayre D., and Lemasters J.J. Mechanisms of hepatotoxicity. Toxicol Sci 65 (2002) 166-176
54. Michael S.L., Pumford N.R., Mayeux P.R., Niesman M.R., and Hinson J.A. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30 (1999) 186-195
55. Gujral J.S., Knight T.R., Farhood A., Bajt M.L., and Jaeschke H. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?. Toxicol Sci 67 (2002) 322-328
56. Muller M., Strand S., Hug H., Heinemann E.M., Walczak H., Hofmann W.J., et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99 (1997) 403-413
57. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2 (2001) 589-598
58. Xiang J., Chao D.T., and Korsmeyer S.J. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci USA 93 (1996) 14559-14563
59. Broker L.E., Kruyt F.A., and Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 11 (2005) 3155-3162
60. Ferri K.F., and Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 3 (2001) E255-E263
61. Bidere N., Lorenzo H.K., Carmona S., Laforge M., Harper F., Dumont C., et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278 (2003) 31401-31411
62. Baehrecke E.H. Autophagic programmed cell death in Drosophila. Cell Death Differ 10 (2003) 940-945
63. Gozuacik D., and Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 (2004) 2891-2906
64. Schweichel J.U., and Merker H.J. The morphology of various types of cell death in prenatal tissues. Teratology 7 (1973) 253-266
65. Lu Z., Dono K., Gotoh K., Shibata M., Koike M., Marubashi S., et al. Participation of autophagy in the degeneration process of rat hepatocytes after transplantation following prolonged cold preservation. Arch Histol Cytol 68 (2005) 71-80
66. Schwarze P.E., and Seglen P.O. Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats. Exp Cell Res 157 (1985) 15-28
67. Shintani T., and Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 306 (2004) 990-995
68. Sperandio S., de Belle I., and Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97 (2000) 14376-14381
69. Sperandio S., Poksay K., de Belle I., Lafuente M.J., Liu B., Nasir J., et al. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ 11 (2004) 1066-1075
70. King K.L., and Cidlowski J.A. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem 58 (1995) 175-180
71. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R., and Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23 (2004) 2825-2837
72. Roninson I.B., Broude E.V., and Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 4 (2001) 303-313
73. Pinkse G.G., Voorhoeve M.P., Noteborn M., Terpstra O.T., Bruijn J.A., and De Heer E. Hepatocyte survival depends on beta1-integrin-mediated attachment of hepatocytes to hepatic extracellular matrix. Liver Int 24 (2004) 218-226
74. Jaeschke H., Gujral J.S., and Bajt M.L. Apoptosis and necrosis in liver disease. Liver Int 24 (2004) 85-89
75. Lovborg H., Gullbo J., and Larsson R. Screening for apoptosis-classical and emerging techniques. Anticancer Drugs 16 (2005) 593-599
76. Dong Z., Saikumar P., Weinberg J.M., and Venkatachalam M.A. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol 151 (1997) 1205-1213
77. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., and Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21 (1995) 1465-1468
78. Jaeschke H., Ho Y.S., Fisher M.A., Lawson J.A., and Farhood A. Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology 29 (1999) 443-450
79. Xu Y., Jones B.E., Neufeld D.S., and Czaja M.J. Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor toxicity. Gastroenterology 115 (1998) 1229-1237
80. Gujral J.S., Farhood A., Bajt M.L., and Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 38 (2003) 355-363
81. Leist M., Single B., Castoldi A.F., Kuhnle S., and Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185 (1997) 1481-1486
82. Nicotera P., and Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 23 (2004) 2757-2765
83. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366 (1998) 177-196
84. Leist M., Gantner F., Jilg S., and Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154 (1995) 1307-1316
85. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8 (2001) 569-581
86. Li J., Bombeck C.A., Yang S., Kim Y.M., and Billiar T.R. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 274 (1999) 17325-17333
87. Vodovotz Y., Kim P.K., Bagci E.Z., Ermentrout G.B., Chow C.C., Bahar I., et al. Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies. Curr Mol Med 4 (2004) 753-762
88. Neumar R.W., Xu Y.A., Gada H., Guttmann R.P., and Siman R. Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J Biol Chem 278 (2003) 14162-14167
89. Yamashima T. Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium 36 (2004) 285-293
90. Rodriguez I., Matsuura K., Ody C., Nagata S., and Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184 (1996) 2067-2072
91. Lacronique V., Mignon A., Fabre M., Viollet B., Rouquet N., Molina T., et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2 (1996) 80-86
92. Streetz K., Leifeld L., Grundmann D., Ramakers J., Eckert K., Spengler U., et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119 (2000) 446-460
93. Schuchmann M., Varfolomeev E.E., Hermann F., Rueckert F., Strand D., Koehler H., et al. Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure. Hepatology 37 (2003) 129-135
94. Zender L., Hutker S., Liedtke C., Tillmann H.L., Zender S., Mundt B., et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 100 (2003) 7797-7802
95. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9 (2003) 347-351
96. Bajt M.L., Vonderfecht S.L., and Jaeschke H. Differential protection with inhibitors of caspase-8 and caspase-3 in murine models of tumor necrosis factor and Fas receptor-mediated hepatocellular apoptosis. Toxicol Appl Pharmacol 175 (2001) 243-252
97. Valentino K.L., Gutierrez M., Sanchez R., Winship M.J., and Shapiro D.A. First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes. Int J Clin Pharmacol Ther 41 (2003) 441-449
98. Contreras J.L., Vilatoba M., Eckstein C., Bilbao G., Anthony Thompson J., and Eckhoff D.E. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice. Surgery 136 (2004) 390-400
99. Natori S., Higuchi H., Contreras P., and Gores G.J. The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl 9 (2003) 278-284
100. Sindram D., Kohli V., Madden J.F., and Clavien P.A. Calpain inhibition prevents sinusoidal endothelial cell apoptosis in the cold ischemic rat liver. Transplantation 68 (1999) 136-140
101. Guicciardi M.E., and Gores G.J. Cheating death in the liver. Nat Med 10 (2004) 587-588
102. McCarthy N.J., Whyte M.K., Gilbert C.S., and Evan G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol 136 (1997) 215-227
103. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., Declercq W., et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187 (1998) 1477-1485
104. Cauwels A., Janssen B., Waeytens A., Cuvelier C., and Brouckaert P. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol 4 (2003) 387-393
105. Ajuebor M.N., Aspinall A.I., Zhou F., Le T., Yang Y., Urbanski S.J., et al. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J Immunol 174 (2005) 8027-8037
106. Chen Y., Wei H., Gao B., Hu Z., Zheng S., and Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat 12 (2005) 38-45
107. Wright M.C., Issa R., Smart D.E., Trim N., Murray G.I., Primrose J.N., et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121 (2001) 685-698